WallStreetZenWallStreetZen

NASDAQ: AUPH
Aurinia Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Aurinia Pharmaceuticals earnings were $39.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest AUPH earnings report on Mar 31, 2025 announced Q1 2025 earnings of $23.3M, up 1,533.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AUPH reported annual earnings of $5.8M, with -107.4% growth. The next AUPH earnings date is Jul 31, 2025.

AUPH earnings history

Current Revenue
$247.3M
Current Earnings
$39.8M
Current Profit Margin
16.1%

AUPH Return on Equity

Current Company
10.8%
Current Industry
-60.2%
Current Market
31.3%
AUPH's Return on Equity (10.8%)... subscribe to Premium to read more.
High Return on Equity Performance

AUPH undefined

Current Company
7.5%
Current Industry
-2.5%
AUPH is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AUPH announces earnings.

AUPH undefined

Current Company
10.64%
Current Industry
5.8%
AUPH has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AUPH vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AUPH$65.88M$39.85MN/A$0.29
NTLA-$515.64M-$525.91MN/A-$5.22
WVE-$103.68M-$112.33MN/A-$0.74
CVAC$256.69M$202.98MN/A$0.91
INVA$14.61M-$59.72MN/A-$0.95
View Top Biotech Stocks

AUPH earnings dates

Next earnings date
Jul 31, 2025

Aurinia Pharmaceuticals Earnings Reports & History FAQ

What were Aurinia Pharmaceuticals's earnings last quarter?

On AUPH's earnings call on Invalid Date, Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q1 2025 earnings per share (EPS) of $0.17, up 342.86% year over year. Total AUPH earnings for the quarter were $23.34 million. In the same quarter last year, Aurinia Pharmaceuticals's earnings per share (EPS) was -$0.07.

If you're new to stock investing, here's how to buy Aurinia Pharmaceuticals stock.

When does Aurinia Pharmaceuticals report earnings?

The next AUPH earnings date is Invalid Date. Add AUPH to your watchlist to be reminded of Aurinia Pharmaceuticals's next earnings date.

Is Aurinia Pharmaceuticals profitable or losing money?

As of the last Aurinia Pharmaceuticals earnings report, Aurinia Pharmaceuticals is currently profitable. Aurinia Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $39.85 million, a 163.69% decrease year over year.

What was AUPH's earnings growth in the past year?

As of Aurinia Pharmaceuticals's earnings date in Invalid Date, Aurinia Pharmaceuticals's earnings has grown year over year. AUPH earnings in the past year totalled $39.85 million.

What are Aurinia Pharmaceuticals's earnings expectations?

The current EPS estimate for Aurinia Pharmaceuticals's earnings report in Invalid Date is $0.14.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.